top of page
News
Pharmacy Benefit Manager Reform Remains Legislative Priority
The 2022 midterms have concluded, but the Republican underperformance is not expected to dampen Congressional enthusiasm for Pharmacy...
Nov 22, 2022
Opinion: Republicans can stand up for patients by lowering out-of-pocket costs
As COVID-19 has dominated health care resources over the past several years, people living with chronic illnesses have faced even greater...
Nov 17, 2022
National Community Pharmacists Association (NCPA) comments to the Federal Trade Commission
The National Community Pharmacists Association (NCPA) welcomes the opportunity to provide comments to the Federal Trade Commission on the...
Nov 4, 2022
New Study: Inequity in PBMs’ Drug Pricing Practices in Oregon Raises Serious Questions
The Oregon State Pharmacy Association (OSPA), in collaboration with 3 Axis Advisors, released a report today that illustrates the...
Oct 27, 2022
Prescription drug pricing reform must rein in pharmacy benefit managers
This month, President Biden signed an executive order directing federal health departments to create plans within 90 days to lower...
Oct 18, 2022
Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, & Providers: A 2022 Update
I conservatively estimate that I’ve created about 1,374,613 slides during my career. But there are two slides that people seem to...
Oct 13, 2022
Opinion: Reforms will lower prescription drug costs for patients and taxpayers
In a win for Texas taxpayers, the state government recently secured $165 million in a lawsuit alleging that the pharmacy benefit manager...
Oct 12, 2022
Medicare Advantage gets exploited by insurers
Insurers have been employing lucrative strategies to milk more money from the federal Medicare Advantage program than they may legally be...
Oct 11, 2022
PBM Accountability Project Managing Director Mark Blum Joins Pharmacy Podcast Network
Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug...
Oct 4, 2022
Time to Rein in the Drug-Industry Middlemen Exploiting Patients
Last month, lawmakers missed a big chance to lower the cost of prescription medicine. Despite including a host of new drug-pricing...
Sep 27, 2022
The Middleman Mentality Is Killing American Medicine
Between producers and consumers, you’ll find a cadre of professionals who broker deals, facilitate transactions, and move goods and...
Sep 26, 2022
Pharmacy Middlemen Deserve Reformers' Attention
Drug pricing reform has received renewed attention in recent months, but one entity always seems to escape unscathed in reform efforts:...
Aug 30, 2022
Charting a Course to Protect Consumers at Pharmacy Counters
There is an Inspector Clouseau quality to how Washington policymakers address the challenge of high prescription drug prices. For years,...
Aug 11, 2022
Fixing the PBM Problem Is the Silver Bullet for Lowering Drug Costs in America
Common Sense PBM Reforms Are Needed Now to Make Medicines More Affordable FOR IMMEDIATE RELEASE August 10, 2022 Washington, DC – Mark...
Aug 11, 2022
How the failure to cap insulin prices impacts Latinos
Failure to include a monthly $35 insulin cap in the climate and health care bill that passed the Senate last weekend could especially...
Aug 9, 2022
Opinion: Congress should seize opportunity to cut medication costs for consumers
Prices are on the rise on just about every category of goods and services: food, housing, and healthcare. Consumers could use a break....
Jul 25, 2022
Opinion: These 'Rebates' Don't Result in Savings
Two former Trump administration officials have taken to the Wall Street Journal to defend the practices of pharmacy benefit managers,...
Jul 22, 2022
Opinion: Drug Prices Are Falling, If You Know Where to Look
Prescription-drug prices are actually falling if you strip out the massive and growing rebates that pharmaceutical companies must pay...
Jul 21, 2022
Statement on Near-Term Congressional Efforts to Improve Prescription Drug Affordability
Congress should prioritize affordability of medicines needed by Medicare beneficiaries suffering from diabetes and other chronic...
Jul 15, 2022
Opinion: San Diegans with Mental Health Issues Forego Treatment Due to High Cost
Rising health care costs continue to put treatment out of reach for vulnerable communities in San Diego and across California, including...
Jul 3, 2022
PBMs are inflating the cost of generic drugs. They must be reined in
hese are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit...
Jun 30, 2022
Talking Solutions: The Story Behind Prescription Drug Prices In Nevada
According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across...
Jun 27, 2022
PBM reform bill that boosts FTC powers inches closer to passage in Senate
Legislation aimed at curbing several pharmacy benefit manager practices such as spread pricing cleared a key obstacle to passage in the...
Jun 22, 2022
Let My Doctors Decide: A VICTORY FOR PATIENTS
The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...
Jun 16, 2022
bottom of page